Paratek Pharmaceuticals Inc expected to post earnings of 32 cents a share - Earnings Preview

Paratek Pharmaceuticals

06/08/2021 21:51

* Paratek Pharmaceuticals Inc  PRTK.OQ   PRTK.O  is expected
to show a rise in quarterly revenue when it reports results on
August 9. 
* The Boston, Massachusetts-based company is expected to report 
 a 554.0% increase in revenue to $60.988 million from $9.33
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Paratek Pharmaceuticals
Inc is for earnings of 32 cents per share. For the same quarter
last year, the company reported a loss of 53 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Paratek
Pharmaceuticals Inc is $15​, about 62.8% above​ its last closing
price of $5.58. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.40       -0.38      -0.39     Missed  -2.1
 Dec. 31 2020  -0.12       -0.04      -0.60     Missed  -1,233
                                                        .3
 Sep. 30 2020  -0.61       -0.61      -0.46     Beat    24.6​
 Jun. 30 2020  -0.23       -0.06      -0.53     Missed  -748
 Mar.          -0.88​      -0.80      -0.66     Beat    17.8​
 31​ 2020​                                              
 Dec. 31 2019  -0.75       -0.81      -0.81     Met     -0.2​
 Sep. 30 2019  -1.04       -1.05      -1.00     Beat    4.5
 Jun. 30 2019  -1.16       -1.16      -1.02     Beat    11.9
 This summary was machine generated August 6 at 20:51 GMT.  All
figures in US dollars unless otherwise stated